Tyrosine Kinase Inhibition in Leukemia Induces an Altered Metabolic State Sensitive to Mitochondrial Perturbations-Reference-Cited by-同舟云学术

Tyrosine Kinase Inhibition in Leukemia Induces an Altered Metabolic State Sensitive to Mitochondrial Perturbations

Published:2014-12-29 Issue:6 Volume:21 Page:1360-1372
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Alvarez-Calderon Francesca,Gregory Mark A.,Pham-Danis Catherine,DeRyckere Deborah,Stevens Brett M.,Zaberezhnyy Vadym,Hill Amanda A.,Gemta Lelisa,Kumar Amit,Kumar Vijay,Wempe Michael F.,Pollyea Daniel A.,Jordan Craig T.,Serkova Natalie J.,Graham Douglas K.,DeGregori James

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Key role of glutamine metabolism in persistence of leukemic cells upon exposition to FLT3 tyrosine kinase inhibitors;Experimental Hematology;2024-09

2. Chemoproteomics Reveals Glaucocalyxin A Induces Mitochondria‐Dependent Apoptosis of Leukemia Cells via Covalently Binding to VDAC1;Advanced Biology;2023-12-17

3. Synergistic lethality in chronic myeloid leukemia – targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment;BMC Cancer;2023-11-27

4. Chemobrain in blood cancers: How chemotherapeutics interfere with the brain's structure and functionality, immune system, and metabolic functions;Medicinal Research Reviews;2023-06-02

5. Identification of the cuproptosis-related hub genes and therapeutic agents for sarcopenia;Frontiers in Genetics;2023-03-17